EU Clears $40B Kimberly-Clark-Kenvue Deal With Divestitures
KVUE sits 26% above its 52-week low of $14.02.
Summary
The European Commission granted conditional approval for Kimberly-Clark's $40B acquisition of Kenvue, requiring divestiture of tampon and feminine hygiene brands in the EEA. Dilek was approved as the buyer for those divested businesses. This follows Australia's conditional clearance in September, which required divesting Carefree and Stayfree in Australia and New Zealand. The EU decision removes a major regulatory hurdle and brings the deal closer to closing. The merger was confirmed in Kenvue's Q2 8-K, and the company recently amended bond indentures to remove restrictive covenants effective upon settlement, signaling preparation for the transaction.
At the time of this announcement, KVUE was trading at $17.65 on NYSE in the Trade & Services sector, with a market capitalization of approximately $33.9B. The 52-week trading range was $14.02 to $20.13. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.